Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$0.64 - $0.78 $1,161 - $1,415
-1,815 Reduced 63.86%
1,027 $1,000
Q4 2023

Feb 06, 2024

SELL
$0.68 - $2.39 $207 - $728
-305 Reduced 9.69%
2,842 $2,000
Q1 2023

May 02, 2023

SELL
$3.94 - $7.05 $2,840 - $5,083
-721 Reduced 18.64%
3,147 $12,000
Q2 2022

Aug 15, 2022

SELL
$3.26 - $7.06 $3,093 - $6,699
-949 Reduced 19.7%
3,868 $15,000
Q1 2022

Jun 30, 2022

BUY
$6.75 - $13.52 $32,514 - $65,125
4,817 New
4,817 $33,000

Others Institutions Holding ALVR

About Allovir, Inc.


  • Ticker ALVR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,063,400
  • Market Cap $51.2M
  • Description
  • Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...
More about ALVR
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.